TAT-2000C Temporal Artery Home Thermometer with SafetyScan Caps
NEW Exergen TemporalScanner SmartGlow home model with 25 SafetyScan Caps.
Protect your family's health with reusable caps for the TAT-2000C Temporal Artery Home Thermometer. Non contact thermometers are proven inaccurate by FDA studies and should not be used. Exergen Temporal Artery Thermometers with SafetyScan Caps are proven to be safe and accurate for fast public temperature screening.
- Temporal thermometer lets you take your child's temperature without any fuss or discomfort
- Thermometer memory remembers last 8 readings so you can easily track fever progression
- Soft-glow display lets you check temperature even in a dark room
- Silent mode for taking temperatures while someone is sleeping.
- Easily switch between Fahrenheit to Celsius with one button.
- The technology has been proven accurate by more than 100 published clinical studies.
- Includes pack of 25 SafetyScan Caps for professionally accurate and safe home & public temperature screening with the Exergen TAT-2000C
- Dimensions (Overall): 1.8 Inches (L), 7.0 Inches (H) x 1.5 Inches (W)
- Weight: .4 Pounds
- Suggested Age: Newborns and Up
- Health Facts: Mercury-Free
- Display Indicators: Temperature
- Includes: Protective Cover, Instruction Manual, Battery
- Material: Plastic
- Features: LCD Display, Digital, Results in Fahrenheit, Instant On, Automatic Shut-Off, Results in Celsius
- Power Source: Battery
- Battery: 1 9-Volt Alkaline, Required, Included
- Care & Cleaning: Spot or Wipe Clean
- Warranty: 5-year warranty
How to Use the Exergen SafetyScan Caps
Step 1. Remove clear protective cap.
Step 2. Place one black SafetyScan cap on probe head.
Step 3. Place the probe on the center of the forehead.
Use Exergen SafetyScan Caps for Accurate Fever Screening
Compare the temperature reading to circadian correction chart at right for the local time. If temperature is above the fever temperature, the scanned person has a fever.
Information in this chart was obtained from a multi-year study with more than 90,000 temperatures collected using Exergen temporal artery thermometers at a leading U.S. medical center.2 Values are average patient temperature plus 2 standard deviations, stratified by time. In the study, the across-day average plus 2 standard deviations was 100.4°F (38.0°C), matching the traditional fever definition.
- Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA 1992;268:1578–80.
- Harding C, Pompei F, Bordonaro SF, McGillicuddy DC, Burmistrov D, Sanchez LD. Fever incidence is much lower in the morning than the evening: Boston and US national triage data. West J Emerg Med 2020;21:909–17.
- Roy S, Powell K, Gerson LW. Temporal artery temperature measurements in healthy infants, children, and adolescents. Clin Pediatr 2003;42:433-7.
Exergen Temporal Artery Thermometers are not NCITs
FDA Studies Prove Non-Contact Infrared Thermometers (NCITs) Are Not Reliable For Detecting Fevers.1,2
Non-Contact Infrared Thermometers (NCITs) have errors due to skin emissivity, skin ambient temperatures, variable perfusion on face, perspiration on face, adding up to an error range of up to 4 deg C (7 deg F), that cannot be eliminated.4 NCITs have NO peer-reviewed published clinical studies supporting their accuracy.
Exergen TemporalScanner Thermometers Are Not NCITs, and Are Proven Accurate in Detecting Fevers by More Than 100 Peer-Reviewed Published Clinical Studies.3
Exergen TemporalScanner Thermometers lightly scan the forehead from the center to the hairline, which will always cross the temporal artery. The TemporalScanner takes approximately 3000 measurements during the scan, retaining the highest, the most accurate, and discarding the rest, and with Exergen’s patented arterial heat balance method (AHB) with patented emissivity correcting infrared sensor system, eliminate the errors that NCITs cannot eliminate, resulting in a medically accurate thermometer backed by more than 100 peer-reviewed published clinical studies.5